Neuropsychopharmacology - Table of Contents alert Volume 37 Issue 10

TABLE OF CONTENTS Volume 37, Issue 10 (September 2012) In this issue Original Articles Corrigenda Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Neuropsychopharmacology focuses on clinical and basic science contributions that advance the understanding of brain and behavior, especially as related to the molecular, cellular, physiological and psychological properties of agents acting within the central nervous system and the identification of the new molecular targets for the development of the next generation of drugs. Reshape the field by submitting your best research Today!   Original Articles Top Prevention of the Phencyclidine-Induced Impairment in Novel Object Recognition in Female Rats by Co-Administration of Lurasidone or Tandospirone, a 5-HT1A Partial Agonist Masakuni Horiguchi, Kayleen E Hannaway, Adesewa E Adelekun, Karu Jayathilake and Herbert Y Meltzer Neuropsychopharmacology 2012 37: 2175-2183; advance online publication, June 27, 2012; 10.1038/npp.2012.64 Abstract | Full Text The Effect of Chronic Cannabinoids on Broadband EEG Neural Oscillations in Humans Patrick D Skosnik, Deepak C D'Souza, Adam B Steinmetz, Chad R Edwards, Jennifer M Vollmer, William P Hetrick and Brian F O'Donnell Neuropsychopharmacology 2012 37: 2184-2193; advance online publication, June 20, 2012; 10.1038/npp.2012.65 Abstract | Full Text Acute Stress Induces Selective Alterations in Cost/Benefit Decision-Making Naghmeh Shafiei, Megan Gray, Victor Viau and Stan B Floresco Neuropsychopharmacology 2012 37: 2194-2209; advance online publication, May 9, 2012; 10.1038/npp.2012.69 Abstract | Full Text Neurogenesis-Independent Antidepressant-Like Effects on Behavior and Stress Axis Response of a Dual Orexin Receptor Antagonist in a Rodent Model of Depression Mathieu Nollet, Philippe Gaillard, Arnaud Tanti, Virginie Girault, Catherine Belzung and Samuel Leman Neuropsychopharmacology 2012 37: 2210-2221; advance online publication, June 20, 2012; 10.1038/npp.2012.70 Abstract | Full Text Amygdala Subregions Tied to SSRI and Placebo Response in Patients with Social Anxiety Disorder Vanda Faria, Lieuwe Appel, Fredrik Åhs, Clas Linnman, Anna Pissiota, Örjan Frans, Massimo Bani, Paolo Bettica, Emilio M Pich, Eva Jacobsson, Kurt Wahlstedt, Mats Fredrikson and Tomas Furmark Neuropsychopharmacology 2012 37: 2222-2232; advance online publication, May 23, 2012; 10.1038/npp.2012.72 Abstract | Full Text Early Prefrontal Functional Blockade in Rats Results in Schizophrenia-Related Anomalies in Behavior and Dopamine Francisca Meyer and Alain Louilot Neuropsychopharmacology 2012 37: 2233-2243; advance online publication, May 16, 2012; 10.1038/npp.2012.74 Abstract | Full Text Serotonin Modulates the Effects of Pavlovian Aversive Predictions on Response Vigor Molly J Crockett, Luke Clark, Annemieke M Apergis-Schoute, Sharon Morein-Zamir and Trevor W Robbins Neuropsychopharmacology 2012 37: 2244-2252; advance online publication, May 30, 2012; 10.1038/npp.2012.75 Abstract | Full Text Yohimbine Depresses Excitatory Transmission in BNST and Impairs Extinction of Cocaine Place Preference Through Orexin-Dependent, Norepinephrine-Independent Processes Kelly L Conrad, Adeola R Davis, Yuval Silberman, Douglas J Sheffler, Angela D Shields, Sam A Saleh, Namita Sen, Heinrich JG Matthies, Jonathan A Javitch, Craig W Lindsley and Danny G Winder Neuropsychopharmacology 2012 37: 2253-2266; advance online publication, May 23, 2012; 10.1038/npp.2012.76 Abstract | Full Text Withdrawal-Associated Increases and Decreases in Functional Neural Connectivity Associated with Altered Emotional Regulation in Alcoholism Owen G O'Daly, Leanne Trick, Jess Scaife, Jane Marshall, David Ball, Mary L Phillips, Stephen SC Williams, David N Stephens and Theodora Duka Neuropsychopharmacology 2012 37: 2267-2276; advance online publication, May 23, 2012; 10.1038/npp.2012.77 Abstract | Full Text Previous Exposure to Nicotine Enhances the Incentive Motivational Effects of Amphetamine via Nicotine-Associated Contextual Stimuli James J Cortright, Georgia R Sampedro, Nichole M Neugebauer and Paul Vezina Neuropsychopharmacology 2012 37: 2277-2284; advance online publication, May 23, 2012; 10.1038/npp.2012.80 Abstract | Full Text Reduced Levels of Serotonin 2A Receptors Underlie Resistance of Egr3-Deficient Mice to Locomotor Suppression by Clozapine Alison A Williams, Wendy M Ingram, Sarah Levine, Jack Resnik, Christy M Kamel, James R Lish, Diana I Elizalde, Scott A Janowski, Joseph Shoker, Alexey Kozlenkov, Javier González-Maeso and Amelia L Gallitano Neuropsychopharmacology 2012 37: 2285-2298; advance online publication, June 13, 2012; 10.1038/npp.2012.81 Abstract | Full Text Low Doses of 17β-Estradiol Rapidly Improve Learning and Increase Hippocampal Dendritic Spines Anna Phan, Christopher S Gabor, Kayla J Favaro, Shayna Kaschack, John N Armstrong, Neil J MacLusky and Elena Choleris Neuropsychopharmacology 2012 37: 2299-2309; advance online publication, June 6, 2012; 10.1038/npp.2012.82 Abstract | Full Text Galantamine, an Acetylcholinesterase Inhibitor and Positive Allosteric Modulator of Nicotinic Acetylcholine Receptors, Attenuates Nicotine Taking and Seeking in Rats Thomas J Hopkins, Laura E Rupprecht, Matthew R Hayes, Julie A Blendy and Heath D Schmidt Neuropsychopharmacology 2012 37: 2310-2321; advance online publication, June 6, 2012; 10.1038/npp.2012.83 Abstract | Full Text Severe Cross-Modal Object Recognition Deficits in Rats Treated Sub-Chronically with NMDA Receptor Antagonists are Reversed by Systemic Nicotine: Implications for Abnormal Multisensory Integration in Schizophrenia Derek L Jacklin, Amit Goel, Kyle J Clementino, Alexander W M Hall, John C Talpos and Boyer D Winters Neuropsychopharmacology 2012 37: 2322-2331; advance online publication, June 6, 2012; 10.1038/npp.2012.84 Abstract | Full Text Influence of δ-Opioid Receptors in the Behavioral Effects of Nicotine Fernando Berrendero, Ainhoa Plaza-Zabala, Lola Galeote, África Flores, S Andreea Bura, Brigitte L Kieffer and Rafael Maldonado Neuropsychopharmacology 2012 37: 2332-2344; advance online publication, June 6, 2012; 10.1038/npp.2012.88 Abstract | Full Text Corrigenda Top The Neuropeptide Galanin and Variants in the GalR1 Gene are Associated with Nicotine Dependence Kia J Jackson, Xiangning Chen, Michael F Miles, JoLynne Harenza and M Imad Damaj Neuropsychopharmacology 2012 37: 2345; 10.1038/npp.2012.95 Full Text Fluoxetine Alleviates Behavioral Depression while Decreasing Acetylcholine Release in the Nucleus Accumbens Shell David T Chau, Pedro V Rada, Kay Kim, Rebecca A Kosloff and Bartley G Hoebel Neuropsychopharmacology 2012 37: 2346; 10.1038/npp.2012.96 Full Text Advertisement Neuropsychopharmacology Brainpod: Neurotherapeutics The brain is a daunting therapeutic challenge. This year's edition of Neuropsychopharmacology Reviews provides an update on treatments for brain disorders ranging from schizophrenia to neurodegeneration. Join Kerri Smith as she talks to Gwenn Smith, editor of this year's volume, about current therapies such as drugs, electrical stimulation and cognitive therapies, and the future of neurotherapeutics in an era of uncertain funding. Visit www.nature.com/npp/podcast   Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.